Robert C. Gallo Looks Beyond NIH and Defends The Past

Interview With: FRANKLIN HOKE, pp.12 Date: November 14, 1994 Gallo's Laboratory of Tumor Cell Biology in the National Cancer Institute at the National Institutes of Health developed a blood test to detect HIV antibodies and thus help ensure virus-free blood supplies worldwide. But shortly after the lab's findings were announced, information emerged that researchers in the laboratory of Luc Montagnier at the Institut Pasteur in P

Written byFranklin Hoke
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Interview With: FRANKLIN HOKE, pp.12
Date: November 14, 1994

Gallo's Laboratory of Tumor Cell Biology in the National Cancer Institute at the National Institutes of Health developed a blood test to detect HIV antibodies and thus help ensure virus-free blood supplies worldwide. But shortly after the lab's findings were announced, information emerged that researchers in the laboratory of Luc Montagnier at the Institut Pasteur in Paris had been the ones to first identify a virus they called LAV, and had, in fact, supplied Gallo's lab with early isolates -- later shown to be genetically identical to Gallo's HTLV-III virus. The revelation strongly suggested that Gallo had taken credit for a discovery that was not his. Years of United States government investigations of alleged misconduct by Gallo and his researchers in his lab ensued, as well as difficult discussions between U.S. and French officials concerning what should constitute a fair apportionment ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies